Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of
1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. G8566R102
(1) Calculation of the foregoing percentage is based on 20,000,000 Class A ordinary shares of Summit Healthcare
Acquisition Corp. (the “Issuer”) outstanding as of November 19, 2021, as disclosed in the Issuer’s Form 10-Q filed with the Securities and Exchange Commission (“SEC”) on November 22, 2021.
CUSIP No. G8566R102
(1) Calculation of the foregoing percentage is based on 20,000,000 Class A ordinary shares of the Issuer outstanding
as of November 19, 2021, as disclosed in the Issuer’s Form 10-Q filed with the SEC on November 22, 2021.
CUSIP No. G8566R102
(1) Calculation of the foregoing percentage is based on 20,000,000 Class A ordinary shares of the Issuer outstanding
as of November 19, 2021, as disclosed in the Issuer’s Form 10-Q filed with the SEC on November 22, 2021.
CUSIP No. G8566R102
(1) Calculation of the foregoing percentage is based on 20,000,000 Class A ordinary shares of the Issuer outstanding
as of November 19, 2021, as disclosed in the Issuer’s Form 10-Q filed with the SEC on November 22, 2021.
CUSIP No. G8566R102
(1) Calculation of the foregoing percentage is based on 20,000,000 Class A ordinary shares of the Issuer outstanding
as of November 19, 2021, as disclosed in the Issuer’s Form 10-Q filed with the SEC on November 22, 2021.
CUSIP No. G8566R102
(1) Calculation of the foregoing percentage is based on 20,000,000 Class A ordinary shares of the Issuer outstanding as of November 19, 2021, as disclosed in
the Issuer’s Form 10-Q filed with the SEC on November 22, 2021.
SCHEDULE 13G
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: February 11, 2022